|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/57 | |
| A61P 7/10 | |||
| A61P 9/10 |
| (11) | Number of the document | 2793935 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12808401.9 |
| Date of filing the European patent application | 2012-12-21 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/076691 |
| Date | 2012-12-21 |
| (87) | Number | WO 2013/093027 |
| Date | 2013-06-27 |
| (30) | Number | Date | Country code |
| 11195254 | 2011-12-22 | EP | |
| 201261587371 P | 2012-01-17 | US |
| (72) |
KLEINSCHNITZ, Christoph, DE
NOLTE, Marc, DE
STOLL, Guido, DE
DICKNEITE, Gerhard, DE
SCHULTE, Stefan, DE
NIESWANDT, Bernhard, DE
PRAGST, Ingo, DE
|
| (73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | USE OF C1-INHIBITOR FOR THE TREATMENT OF SECONDARY EDEMA OF THE CENTRAL NERVOUS SYSTEM |
| USE OF C1-INHIBITOR FOR THE TREATMENT OF SECONDARY EDEMA OF THE CENTRAL NERVOUS SYSTEM |